Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S086 in Mild to Moderate Essential Hypertension
NCT05033535Phase 2Unknown
- Sponsor
- Shenzhen People's Hospital
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of S086 in essential hypertension, sponsored by Shenzhen People's Hospital. Status: unknown.
02
Drugs
S086
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT05033535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05033535.